ECG criteria
- Measure the QT interval in a lead with clear QRS onset and T wave end (typically II or V5–V6), and average the values over several cycles
- Calculate QTc using Bazett's formula (QTc = QT / √RR)—diagnostic thresholds for SQTS are specifically validated for this formula; if heart rate deviates significantly from 60–100 bpm, additionally cross-check with Fridericia's or Hodges' formulas and repeat the ECG after heart rate stabilization, keeping in mind that thresholds for different formulas are not interchangeable
- QTc ≤ 360 ms is an indication for further workup. QTc ≤ 320 ms is considered the most convincing standalone ECG criterion in the 2022 ESC guidelines. A QTc of 320–360 ms requires additional features: history of cardiac arrest, unexplained syncope, family history of premature sudden death, pathogenic mutation, or atrial fibrillation in a young patient. The diagnosis must always be evaluated in the clinical context rather than based on an isolated value
- Evaluate the T wave: narrow, tall, symmetrical, with a short or absent ST segment (QRS transitions directly into the T wave with virtually no ST segment)
- Assess QT/RR adaptation: in some SQTS patients, the QT interval does not prolong sufficiently during bradycardia—this is a supportive, though not mandatory, sign
- Rule out secondary causes of a short QT interval (hypercalcemia, hyperthermia, acidosis, digoxin, hyperkalemia)
- Evaluate family history: sudden death, syncope, documented ventricular fibrillation in relatives
- When in doubt, use the Gollob scoring system incorporating QTc, clinical presentation, and genetics
What it looks like on ECG
The basis of diagnosis is a shortened rate-corrected QT interval (QTc). Measurement should be performed in the lead with the most distinct T wave termination, frequently II or V5–V6; it is advisable to average the value over 3–5 cardiac cycles, especially in the presence of sinus arrhythmia.
Threshold values from various sources differ:
| Criterion | QTc | Source/Interpretation |
|---|---|---|
| Most convincing ECG criterion | ≤ 320 ms | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death |
| Diagnostically significant with additional criteria | 320–360 ms | 2022 ESC: clinical, familial, or genetic features are required |
| Highly specific (historical case series) | ≤ 330 ms | Classic descriptions of SQTS, previous consensus statements |
| Suspicious, requires further evaluation | ≤ 360 ms | Selected guidelines and risk scoring systems |
The T wave in SQTS is typically tall, narrow, and symmetrical; the ST segment is markedly shortened or practically absent—the QRS complex merges into the T wave with almost no isoelectric segment. This distinguishes SQTS from simple tachycardia-induced QT shortening, where T-wave morphology does not undergo such pronounced changes.
Heart rate and QRS duration remain normal in typical cases. Some patients exhibit abnormal QT/RR adaptation, including inadequate QT prolongation during bradycardia—this is a supportive rather than obligatory criterion and is not detected in all patients with SQTS.
Mechanism
SQTS is driven by ion channel gene mutations that either enhance outward potassium currents (gain-of-function) or diminish inward calcium currents (loss-of-function in genes encoding L-type calcium channels). The ultimate result is shortening of phases 2 and 3 of the cardiomyocyte action potential and, consequently, shortening of the ventricular refractory period.
A short refractory period creates a substrate for re-entry: different myocardial areas recover excitability at different times, and a premature impulse (e.g., an extrasystole) can trigger a re-entrant circuit leading to polymorphic ventricular tachycardia or ventricular fibrillation.
Causes
- Congenital form—the most well-established cause: mutations in potassium channel genes KCNH2 (SQT1) and KCNQ1 (SQT2); inheritance is autosomal dominant
- Historically proposed and rarer or ambiguously confirmed genetic variants include KCNJ2 mutations (SQT3, a gene primarily associated with Andersen–Tawil syndrome) and calcium channel genes CACNA1C, CACNB2, and CACNA2D1 (designated as SQT4–SQT6); the causative link between these variants and SQTS, as well as the nomenclature of SQT3–SQT6, remains a subject of debate
- A significant proportion of clinically diagnosed cases have no identified mutation (idiopathic SQTS); a negative genetic test result does not rule out the diagnosis
- Secondary QT shortening (not a true syndrome, but produces a similar ECG pattern): hypercalcemia, hyperthermia, acidosis, digitalis toxicity, hyperkalemia, elevated sympathetic tone
Differential diagnosis
- Simple QT shortening during tachycardia—T-wave and ST-segment morphology do not change as dramatically, and QTc remains within normal limits upon recalculation
- Secondary short QT due to hypercalcemia, hyperthermia, acidosis, or digoxin administration—look for relevant history and laboratory findings; QTc normalizes after the underlying cause is corrected
- Early repolarization syndrome—elevation of the J point and ST segment, QTc is typically not shortened to this extent
- An isolated short QTc, particularly in the 330–360 ms range, may be a normal variant, but it should be assessed considering sex, age, T-wave morphology, repeat ECGs, symptoms, and family history; a negative family history does not exclude SQTS
Clinical significance and management
SQTS is associated with a high risk of polymorphic ventricular tachycardia, ventricular fibrillation, and sudden cardiac death, including in young and previously asymptomatic individuals; cases manifesting in infancy and old age have been described. There is also an increased risk of atrial fibrillation, even in young patients without structural heart disease.
When SQTS is suspected on an ECG, the clinician should: rule out secondary causes of short QT (calcium, temperature, acid-base balance, medications), obtain a family history of syncope and sudden death, refer the patient for genetic counseling and testing, and consider risk stratification using scoring systems (e.g., Gollob score). Implantable cardioverter-defibrillator (ICD) implantation is recommended after a cardiac arrest secondary to VT/VF; it should also be considered in patients with documented spontaneous sustained ventricular tachycardia, even without overt hemodynamic compromise. Primary prevention in asymptomatic patients, even those with a short QTc, is not an automatic indication and must be decided on an individual basis in a specialized arrhythmology center, taking into account age and the risk of ICD complications. Pharmacotherapy, including quinidine/hydroquinidine, may be used when ICD implantation is not feasible, refused by the patient, or contraindicated, as well as adjunctive therapy in ICD recipients with recurrent ventricular arrhythmias or appropriate repeated device therapies; the evidence base and drug selection are limited, and the decision rests with a specialized center.
Common interpretation errors
- Measuring QT in a single lead without accounting for potential variations in other leads due to artifacts or low-amplitude T waves
- Calculating QTc using a single formula without specifying which one was used, and applying SQTS thresholds (validated for Bazett's formula) to values obtained using a different formula
- Ignoring T-wave and ST-segment morphology—evaluating QTc solely as a number while missing the characteristic tall, narrow T wave with no ST segment
- Diagnosing SQTS based solely on a QTc value of ≤ 330–360 ms without considering clinical presentation, family history, and the exclusion of secondary causes of short QT
- Underestimating a short QT interval as an incidental finding without referring the patient for further evaluation in the presence of a family history
1. Which QTc value in the 2022 ESC criteria is considered the most convincing standalone ECG criterion for short QT syndrome?
In the 2022 ESC guidelines, a QTc of ≤ 320 ms is considered the most convincing ECG criterion for SQTS. For comparison, the upper limit of normal for Bazett-corrected QTc is approximately 440 ms in men and 460 ms in women, with reference ranges depending on sex, age, heart rate, and the correction formula used.
2. Which T-wave and ST-segment feature is typical for short QT syndrome?
In SQTS, the T wave is tall, narrow, and symmetrical, while the ST segment is markedly shortened or absent—the QRS complex transitions into the T wave almost immediately.
3. Which rhythm disturbance is most characteristic as a cause of sudden death in short QT syndrome?
The shortened ventricular refractory period creates a substrate for re-entry, leading to polymorphic ventricular tachycardia and ventricular fibrillation.
Frequently asked questions
What QTc is considered short for the diagnosis of SQTS?
There is no single rigid threshold. The 2022 ESC guidelines consider QTc ≤ 320 ms as the most convincing standalone ECG criterion, whereas a QTc of 320–360 ms requires additional features—such as a history of cardiac arrest, unexplained syncope, family history of young sudden death, a pathogenic mutation, or AF in a young patient. Older case series cited a threshold of ≤ 330 ms as highly specific. In any case, the diagnosis is evaluated in the clinical context rather than by an isolated number.
Is short QT syndrome dangerous?
Yes, it is associated with an increased risk of polymorphic ventricular tachycardia, ventricular fibrillation, sudden cardiac death, and atrial fibrillation, including in young individuals without structural heart disease.
How to distinguish short QT syndrome from short QT due to tachycardia?
During physiological QT shortening associated with tachycardia, the morphology of the T wave and ST segment does not change markedly, and the QTc usually remains within normal limits after correction. In SQTS, the QTc is persistently shortened, the T wave is tall and narrow, the ST segment is virtually absent, and the short QT is independent of heart rate normalization.
Is genetic testing necessary to confirm the diagnosis?
Genetic testing helps confirm the diagnosis and identify the specific gene (most commonly KCNH2 or KCNQ1, less frequently others), but a mutation is not found in all patients with the clinical presentation of SQTS; therefore, the diagnosis is based on a combination of ECG findings, clinical presentation, and family history.
Which QTc formula should be used when short QT is suspected?
To compare with SQTS diagnostic thresholds, Bazett's formula is typically used, as these thresholds were validated using it. At high heart rates, Fridericia's formula generally reduces Bazett's systematic error, but it is not universally more accurate across all bradycardias; at extreme heart rates, it is useful to additionally evaluate QTc using Fridericia or Hodges and repeat the ECG after rhythm stabilization, keeping in mind that the thresholds for different formulas are not interchangeable.
ECG Course
Interpretation from basics to myocardial infarction — learn to read any ECG using a systematic algorithm.
- Video lessons and theory for every topic
- Simulator case studies under every lesson
- Unlimited ECG simulator practice
- Study guide: "All ECGs in 25 minutes"
ECG Strip Simulator
ECG, radiology, histology, pathomorphology, pharmacology — thousands of flashcards with detailed explanations.
- Real ECG strips, not textbook drawings
- Instant answers and explanations
- Streaks and progress tracking in your dashboard
Related terms
More in the «Channelopathies and Cardiomyopathies» section
Sources
- Goldberger A.L. Clinical Electrocardiography: A Simplified Approach
- Surawicz B., Knilans T. Chou's Electrocardiography in Clinical Practice
- 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram, 2009
Educational material for medical students and physicians. Does not replace clinical guidelines and physical examination; the ECG must always be interpreted in conjunction with the clinical picture.